Evidence map›Paper›PMID 29225413›Full record

ArticleJournal of preventive medicine2017

Outbreak of Hospital Infection from Biofilm-embedded Pan Drug-resistant

Nader Alipour, Alper Karagoz, Abbas Taner, Nasrin Gaeini, Nastaran Alipour, Hassan Zeytin, Fatih Yildiz, Riza Durmaz

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Journal of preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Nader AlipourDepartment of Microbiology & Biotechnology, Metu, Ankara, Turkey.
Alper KaragozDepartment of Molecular Microbiology, Rafik Saydam Hifzi saha, Ankara, Turkey.
Abbas TanerDepartment of Medical Microbiology, Kuru Hospital, Ankara, Turkey.
Nasrin GaeiniDepartment of Radiology, SİFA Medical Center, Gebze, Kocaeli, Turkey.
Nastaran AlipourDepartment of Organic Chemistry, Tabriz University, Tabriz-Iran.
Hassan ZeytinCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Fatih YildizDepartment of Microbiology & Biotechnology, Metu, Ankara, Turkey.
Riza DurmazDepartment of Molecular Microbiology, Rafik Saydam Hifzi saha, Ankara, Turkey.
Middle East Technical University · TRNational Cancer Institute · USŞifa University · TR

Funding

Clinical Pharmacology of Polymyxin BR15AI089671 · NIAID · UNIVERSITY OF HOUSTON · PI TAM, VINCENT H · 2010 to 2010
$450k
6 · The paper itself

Abstract

Background: Colistin-resistant Aim: To report such an outbreak and modify the infection control strategy in an academic hospital in Ankara Turkey. Methods: From October to December 2013, PDR-Pseudomonas aerogionsa were identified from bronchial cultures of 15 patients who had undergone bronchoscopy prior to the infection. Three batches of surveillance cultures were obtained from the environmental objects and healthcare workers related to the procedures. Pulsed-field gel electrophoresis (PFGE) was used for bacterial typing. Antimicrobial susceptibility was assessed by disc diffusion and E-test methods. Findings: A total of 70 specimens were obtained during the first surveillance operation. One Colistin-resistant Conclusion: The outbreak of "Colistin" pan drug-resistant

Indexed as

BronchoscopeDNA finger printingNosocomial infectionPseudomonas aeruginosaPulsedfield gel electrophoresis

Identifiers

PMID29225413
OpenAlexW2769555169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.